- Home
- CHEK vs IMCC Comparison
CHEK vs IMCC Comparison
Compare CHEK & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHEK
- IMCC
- Stock Information
- Founded
- CHEK 2004
- IMCC 1980
- Country
- CHEK Israel
- IMCC Israel
- Employees
- CHEK N/A
- IMCC N/A
- Industry
- CHEK Medical Electronics
- IMCC Medicinal Chemicals and Botanical Products
- Sector
- CHEK Health Care
- IMCC Health Care
- Exchange
- CHEK Nasdaq
- IMCC Nasdaq
- Market Cap
- CHEK 9.0M
- IMCC 7.5M
- IPO Year
- CHEK 2015
- IMCC N/A
- Fundamental
- Price
- CHEK $0.90
- IMCC $2.23
- Analyst Decision
- CHEK
- IMCC
- Analyst Count
- CHEK 0
- IMCC 0
- Target Price
- CHEK N/A
- IMCC N/A
- AVG Volume (30 Days)
- CHEK 88.2K
- IMCC 16.3K
- Earning Date
- CHEK 02-18-2025
- IMCC 03-27-2025
- Dividend Yield
- CHEK N/A
- IMCC N/A
- EPS Growth
- CHEK N/A
- IMCC N/A
- EPS
- CHEK N/A
- IMCC N/A
- Revenue
- CHEK N/A
- IMCC $38,042,859.00
- Revenue This Year
- CHEK N/A
- IMCC $22.59
- Revenue Next Year
- CHEK N/A
- IMCC $32.86
- P/E Ratio
- CHEK N/A
- IMCC N/A
- Revenue Growth
- CHEK N/A
- IMCC N/A
- 52 Week Low
- CHEK $0.56
- IMCC $1.50
- 52 Week High
- CHEK $3.45
- IMCC $8.10
- Technical
- Relative Strength Index (RSI)
- CHEK 43.48
- IMCC 53.35
- Support Level
- CHEK $0.81
- IMCC $2.05
- Resistance Level
- CHEK $0.97
- IMCC $2.60
- Average True Range (ATR)
- CHEK 0.10
- IMCC 0.21
- MACD
- CHEK -0.04
- IMCC 0.02
- Stochastic Oscillator
- CHEK 19.30
- IMCC 58.31
About CHEK Check-Cap Ltd.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.